Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Salivary Gland Neoplasms × Microarray Analysis × Clear all

Sponsor

Conditions

Lymphoma, Large B-Cell, Diffuse 4 Breast Neoplasms 4 Lymphoma, Large-Cell, Anaplastic 3 Immunoblastic Lymphadenopathy 3 Burkitt Lymphoma 3 Sarcoma 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Lymphoma, Extranodal NK-T-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Esophageal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Thrombocytopenia 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Teratoma 1 Spinal Cord Neoplasms 1 Sezary Syndrome 1 Rhabdoid Tumor 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cetuximab 3 Vorinostat 2 Radiosurgery 2 Nivolumab 2 Ipilimumab 2 Dasatinib 2 Cisplatin 2 Bevacizumab 2 temsirolimus 1 pembrolizumab 1 ispinesib 1 eribulin 1 dehydroftorafur 1 apalutamide 1 alectinib 1 Sorafenib 1 Sirolimus 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Moxibustion 1 Magnetic Resonance Spectroscopy 1 MK 2206 1 Lapatinib 1 Irinotecan 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Gemcitabine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡